Rankings
▼
Calendar
AMRN Q3 2023 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$66M
-26.5% YoY
Gross Profit
$30M
45.1% margin
Operating Income
-$21M
-32.5% margin
Net Income
-$19M
-29.2% margin
EPS (Diluted)
$-0.95
QoQ Revenue Growth
-17.6%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$7M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$839M
Total Liabilities
$286M
Stockholders' Equity
$553M
Cash & Equivalents
$271M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$66M
$90M
-26.5%
Gross Profit
$30M
$63M
-52.6%
Operating Income
-$21M
-$5M
-317.0%
Net Income
-$19M
-$5M
-275.7%
Revenue Segments
Product
$65M
98%
Licensing And Royalty
$1M
2%
← FY 2023
All Quarters
Q4 2023 →